Status:
NOT_YET_RECRUITING
Development and Evaluation of an Information Management System and Communication System for Population-wide Point-of-care Infant Sickle Cell Disease Screening
Lead Sponsor:
Makerere University
Collaborating Sponsors:
Baylor College of Medicine
Ministry of Health, Uganda
Conditions:
Sickle Cell Disease
Eligibility:
All Genders
Up to 5 years
Phase:
NA
Brief Summary
Although over 75% of children with sickle cell disease (SCD) are born in sub-Sahara where the disease highly contributes to under-5 mortality and causes life-long debilitation, evidence-based strategi...
Detailed Description
This trial builds on our multidisciplinary experience in pediatric sickle cell disease (SCD) care, mHealth platforms, and community-based research in Uganda to develop, validate, and trial a novel SCD...
Eligibility Criteria
Inclusion
- A participant will be eligible for enrolment if at baseline they are an infant less than 1 year of age and presents to any of the health centers in the communities where the project will be conducted.
Exclusion
- Persons 1 year or older
Key Trial Info
Start Date :
August 21 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2028
Estimated Enrollment :
24000 Patients enrolled
Trial Details
Trial ID
NCT06563440
Start Date
August 21 2024
End Date
July 31 2028
Last Update
August 22 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor College of Medicine
Houston, Texas, United States, 77030
2
College of Health Sciences, Makerere University
Kampala, Uganda, 256